-
1
-
-
0034600849
-
The ErbB signaling network: Receptor heterodimerization in development and cancer
-
Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 2000; 19: 3159-3167. (Pubitemid 30428195)
-
(2000)
EMBO Journal
, vol.19
, Issue.13
, pp. 3159-3167
-
-
Olayioye, M.A.1
Neve, R.M.2
Lane, H.A.3
Hynes, N.E.4
-
3
-
-
66349114704
-
Activation of Src by protein tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells
-
Arias-Romero LE, Saha S, Villamar-Cruz O, Yip SC, Ethier SP, Zhang ZY et al. Activation of Src by protein tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells. Cancer Res 2009; 69: 4582-4588.
-
(2009)
Cancer Res
, vol.69
, pp. 4582-4588
-
-
Arias-Romero, L.E.1
Saha, S.2
Villamar-Cruz, O.3
Yip, S.C.4
Ethier, S.P.5
Zhang, Z.Y.6
-
4
-
-
0029912203
-
All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired
-
DOI 10.1074/jbc.271.9.5251
-
Baulida J, Kraus MH, Alimandi M, Di Fiore PP, Carpenter G. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J Biol Chem 1996; 271: 5251-5257. (Pubitemid 26075021)
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.9
, pp. 5251-5257
-
-
Baulida, J.1
Kraus, M.H.2
Alimandi, M.3
Di Fiore, P.P.4
Carpenter, G.5
-
5
-
-
30544449081
-
A quantitative protein interaction network for the ErbB receptors using protein microarrays
-
DOI 10.1038/nature04177, PII NATURE04177
-
Jones RB, Gordus A, Krall JA, MacBeath G. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 2006; 439: 168-174. (Pubitemid 43083134)
-
(2006)
Nature
, vol.439
, Issue.7073
, pp. 168-174
-
-
Jones, R.B.1
Gordus, A.2
Krall, J.A.3
MacBeath, G.4
-
6
-
-
67649472398
-
Novel anticancer targets: Revisiting ERBB2 and discovering ERBB3
-
Baselga J, Swain SM. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer 2009; 9: 463-475.
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 463-475
-
-
Baselga, J.1
Swain, S.M.2
-
7
-
-
0034327895
-
Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: A direct comparison of fluorescence in situ hybridization and immunohistochemistry
-
Pauletti G, Dandekar S, Rong H, Ramos L, Peng H, Seshadri R et al. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol 2000; 18: 3651-3664.
-
(2000)
J Clin Oncol
, vol.18
, pp. 3651-3664
-
-
Pauletti, G.1
Dandekar, S.2
Rong, H.3
Ramos, L.4
Peng, H.5
Seshadri, R.6
-
8
-
-
37049183697
-
Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
-
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177-182. (Pubitemid 17231334)
-
(1987)
Science
, vol.235
, Issue.4785
, pp. 177-182
-
-
Slamon, D.J.1
Clark, G.M.2
Wong, S.G.3
-
9
-
-
0033142114
-
Prognostic value of plasma HER-2/neu in African American and Hispanic women with breast cancer
-
Wu Y, Khan H, Chillar R, Vadgama JV. Prognostic value of plasma HER-2/neu in African American and Hispanic women with breast cancer. Int J Oncol 1999; 14: 1021-1037.
-
(1999)
Int J Oncol
, vol.14
, pp. 1021-1037
-
-
Wu, Y.1
Khan, H.2
Chillar, R.3
Vadgama, J.V.4
-
10
-
-
0035869407
-
Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses HER2
-
DOI 10.1056/NEJM200103153441101
-
Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344: 783-792. (Pubitemid 32222155)
-
(2001)
New England Journal of Medicine
, vol.344
, Issue.11
, pp. 783-792
-
-
Slamon, D.J.1
Leyland-Jones, B.2
Shak, S.3
Fuchs, H.4
Paton, V.5
Bajamonde, A.6
Fleming, T.7
Eiermann, W.8
Wolter, J.9
Pegram, M.10
Baselga, J.11
Norton, L.12
-
11
-
-
31644439697
-
Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way
-
DOI 10.1242/jcs.02707
-
Lerdrup M, Hommelgaard AM, Grandal M, van Deurs B. Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way. J Cell Sci 2006; 119: 85-95. (Pubitemid 43169301)
-
(2006)
Journal of Cell Science
, vol.119
, Issue.1
, pp. 85-95
-
-
Lerdrup, M.1
Hommelgaard, A.M.2
Grandal, M.3
Van Deurs, B.4
-
12
-
-
0029812759
-
Polyubiquitination and proteasomal degradation of the p185(c-erbB-2) receptor protein-tyrosine kinase induced by geldanamycin
-
DOI 10.1074/jbc.271.37.22796
-
Mimnaugh EG, Chavany C, Neckers L. Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin. J Biol Chem 1996; 271: 22796-22801. (Pubitemid 26304727)
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.37
, pp. 22796-22801
-
-
Mimnaugh, E.G.1
Chavany, C.2
Neckers, L.3
-
13
-
-
0035793546
-
Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90
-
Xu W, Mimnaugh E, Rosser MF, Nicchitta C, Marcu M, Yarden Y et al. Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90. J Biol Chem 2001; 276: 3702-3708.
-
(2001)
J Biol Chem
, vol.276
, pp. 3702-3708
-
-
Xu, W.1
Mimnaugh, E.2
Rosser, M.F.3
Nicchitta, C.4
Marcu, M.5
Yarden, Y.6
-
14
-
-
70649098325
-
Evolving novel anti-HER2 strategies
-
Jones KL, Buzdar AU. Evolving novel anti-HER2 strategies. Lancet Oncol 2009; 10: 1179-1187.
-
(2009)
Lancet Oncol
, vol.10
, pp. 1179-1187
-
-
Jones, K.L.1
Buzdar, A.U.2
-
15
-
-
33749011681
-
A phase I study of cetuximab in combination with paclitaxel in patients with advanced-stage breast cancer
-
Modi S, D'Andrea G, Norton L, Yao TJ, Caravelli J, Rosen PP et al. A phase I study of cetuximab/paclitaxel in patients with advanced-stage breast cancer. Clin Breast Cancer 2006; 7: 270-277. (Pubitemid 44445741)
-
(2006)
Clinical Breast Cancer
, vol.7
, Issue.3
, pp. 270-277
-
-
Modi, S.1
D'Andrea, G.2
Norton, L.3
Yao, T.J.4
Caravelli, J.5
Rosen, P.P.6
Hudis, C.7
Seidman, A.D.8
-
16
-
-
36849055007
-
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: A phase I dose-escalation study
-
DOI 10.1200/JCO.2007.11.7960
-
Modi S, Stopeck AT, Gordon MS, Mendelson D, Solit DB, Bagatell R et al. Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study. J Clin Oncol 2007; 25: 5410-5417. (Pubitemid 350232217)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.34
, pp. 5410-5417
-
-
Modi, S.1
Stopeck, A.T.2
Gordon, M.S.3
Mendelson, D.4
Solit, D.B.5
Bagatell, R.6
Ma, W.7
Wheler, J.8
Rosen, N.9
Norton, L.10
Cropp, G.F.11
Johnson, R.G.12
Hannah, A.L.13
Hudis, C.A.14
-
17
-
-
0031054457
-
Reggie-1 and reggie-2, two cell surface proteins expressed by retinal ganglion cells during axon regeneration
-
Schulte T, Paschke KA, Laessing U, Lottspeich F, Stuermer CA. Reggie-1 and reggie-2, two cell surface proteins expressed by retinal ganglion cells during axon regeneration. Development 1997; 124: 577-587. (Pubitemid 27101691)
-
(1997)
Development
, vol.124
, Issue.2
, pp. 577-587
-
-
Schulte, T.1
Paschke, K.A.2
Laessing, U.3
Lottspeich, F.4
Stuermer, C.A.O.5
-
18
-
-
27144543784
-
Scaffolding microdomains and beyond: The function of reggie/flotillin proteins
-
DOI 10.1007/s00018-005-5166-4
-
Langhorst MF, Reuter A, Stuermer CA. Scaffolding microdomains and beyond: the function of reggie/flotillin proteins. Cell Mol Life Sci 2005; 62: 2228-2240. (Pubitemid 41500540)
-
(2005)
Cellular and Molecular Life Sciences
, vol.62
, Issue.19-20
, pp. 2228-2240
-
-
Langhorst, M.F.1
Reuter, A.2
Stuermer, C.A.O.3
-
19
-
-
1642271441
-
Membrane and raft association of reggie-1/flotillin-2: Role of myristoylation, palmitoylation and oligomerization and induction of filopodia by overexpression
-
DOI 10.1042/BJ20031100
-
Neumann-Giesen C, Falkenbach B, Beicht P, Claasen S, Luers G, Stuermer CA et al. Membrane and raft association of reggie-1/flotillin-2: role of myristoylation, palmitoylation and oligomerization and induction of filopodia by overexpression. Biochem J 2004; 378: 509-518. (Pubitemid 38367240)
-
(2004)
Biochemical Journal
, vol.378
, Issue.2
, pp. 509-518
-
-
Neumann-Giesen, C.1
Falkenbach, B.2
Beicht, P.3
Claasen, S.4
Luers, G.5
Stuermer, C.A.O.6
Herzog, V.7
Tikkanen, R.8
-
20
-
-
0035171631
-
Glycosylphosphatidyl inositol-anchored proteins and fyn kinase assemble in noncaveolar plasma membrane microdomains defined by reggie-1 and -2
-
Stuermer CA, Lang DM, Kirsch F, Wiechers M, Deininger SO, Plattner H. Glycosylphosphatidyl inositol-anchored proteins and fyn kinase assemble in noncaveolar plasma membrane microdomains defined by reggie-1 and -2. Mol Biol Cell 2001; 12: 3031-3045. (Pubitemid 33062959)
-
(2001)
Molecular Biology of the Cell
, vol.12
, Issue.10
, pp. 3031-3045
-
-
Stuermer, C.A.O.1
Lang, D.M.2
Kirsch, F.3
Wiechers, M.4
Deininger, S.-O.5
Plattner, H.6
-
21
-
-
30344486984
-
Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells
-
DOI 10.1038/ncb1342, PII N1342
-
Glebov OO, Bright NA, Nichols BJ. Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat Cell Biol 2006; 8: 46-54. (Pubitemid 43064796)
-
(2006)
Nature Cell Biology
, vol.8
, Issue.1
, pp. 46-54
-
-
Glebov, O.O.1
Bright, N.A.2
Nichols, B.J.3
-
22
-
-
77749249684
-
Interplay between toxin transport and flotillin localization
-
Pust S, Dyve AB, Torgersen ML, van Deurs B, Sandvig K. Interplay between toxin transport and flotillin localization. PLoS One 2010; 5: e8844.
-
(2010)
PLoS One
, vol.5
-
-
Pust, S.1
Dyve, A.B.2
Torgersen, M.L.3
Van Deurs, B.4
Sandvig, K.5
-
23
-
-
78649855802
-
Intoxication of zebrafish and mammalian cells by cholera toxin depends on the flotillin/reggie proteins but not Derlin-1 or -2
-
Saslowsky DE, Cho JA, Chinnapen H, Massol RH, Chinnapen DJ, Wagner JS et al. Intoxication of zebrafish and mammalian cells by cholera toxin depends on the flotillin/reggie proteins but not Derlin-1 or -2. J Clin Invest 2010; 120: 4399-4409.
-
(2010)
J Clin Invest
, vol.120
, pp. 4399-4409
-
-
Saslowsky, D.E.1
Cho, J.A.2
Chinnapen, H.3
Massol, R.H.4
Chinnapen, D.J.5
Wagner, J.S.6
-
24
-
-
33751252292
-
Direct observation of individual endogenous protein complexes in situ by proximity ligation
-
DOI 10.1038/nmeth947, PII NMETH947
-
Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius KJ, Jarvius J et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 2006; 3: 995-1000. (Pubitemid 44782698)
-
(2006)
Nature Methods
, vol.3
, Issue.12
, pp. 995-1000
-
-
Soderberg, O.1
Gullberg, M.2
Jarvius, M.3
Ridderstrale, K.4
Leuchowius, K.-J.5
Jarvius, J.6
Wester, K.7
Hydbring, P.8
Bahram, F.9
Larsson, L.-G.10
Landegren, U.11
-
25
-
-
84859109522
-
In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer
-
Spears M, Taylor KJ, Munro AF, Cunningham CA, Mallon EA, Twelves CJ et al. In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer. Breast Cancer Res Treat 2012; 132: 463-470.
-
(2012)
Breast Cancer Res Treat
, vol.132
, pp. 463-470
-
-
Spears, M.1
Taylor, K.J.2
Munro, A.F.3
Cunningham, C.A.4
Mallon, E.A.5
Twelves, C.J.6
-
26
-
-
1942431966
-
The Achilles heel of ErbB-2/HER2: Regulation by the Hsp90 chaperone machine and potential for pharmacological intervention
-
Citri A, Kochupurakkal BS, Yarden Y. The achilles heel of ErbB-2/HER2: regulation by the Hsp90 chaperone machine and potential for pharmacological intervention. Cell Cycle 2004; 3: 51-60. (Pubitemid 40268587)
-
(2004)
Cell Cycle
, vol.3
, Issue.1
, pp. 51-60
-
-
Citri, A.1
Kochupurakkal, B.S.2
Yarden, Y.3
-
27
-
-
0037291226
-
The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors
-
DOI 10.1016/S1097-2765(03)00048-0
-
Garrett TP, McKern NM, Lou M, Elleman TC, Adams TE, Lovrecz GO et al. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. Mol Cell 2003; 11: 495-505. (Pubitemid 36293841)
-
(2003)
Molecular Cell
, vol.11
, Issue.2
, pp. 495-505
-
-
Garrett, T.P.J.1
McKern, N.M.2
Lou, M.3
Elleman, T.C.4
Adams, T.E.5
Lovrecz, G.O.6
Kofler, M.7
Jorissen, R.N.8
Nice, E.C.9
Burgess, A.W.10
Ward, C.W.11
-
28
-
-
33644750227
-
Phosphorylation of tyrosine 1248-ERBB2 measured by chemiluminescence- linked immunoassay is an independent predictor of poor prognosis in primary breast cancer patients
-
DOI 10.1016/j.ejca.2005.11.012, PII S095980490501066X
-
Cicenas J, Urban P, Kung W, Vuaroqueaux V, Labuhn M, Wight E et al. Phosphorylation of tyrosine 1248-ERBB2 measured by chemiluminescence-linked immunoassay is an independent predictor of poor prognosis in primary breast cancer patients. Eur J Cancer 2006; 42: 636-645. (Pubitemid 43343686)
-
(2006)
European Journal of Cancer
, vol.42
, Issue.5
, pp. 636-645
-
-
Cicenas, J.1
Urban, P.2
Kung, W.3
Vuaroqueaux, V.4
Labuhn, M.5
Wight, E.6
Eppenberger, U.7
Eppenberger-Castori, S.8
-
29
-
-
33746257209
-
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
-
DOI 10.1038/nrg1879, PII NRG1879
-
Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006; 7: 606-619. (Pubitemid 44100518)
-
(2006)
Nature Reviews Genetics
, vol.7
, Issue.8
, pp. 606-619
-
-
Engelman, J.A.1
Luo, J.2
Cantley, L.C.3
-
30
-
-
51849111556
-
PI3K pathway alterations in cancer: Variations on a theme
-
Yuan TL, Cantley LC. PI3K pathway alterations in cancer: variations on a theme. Oncogene 2008; 27: 5497-5510.
-
(2008)
Oncogene
, vol.27
, pp. 5497-5510
-
-
Yuan, T.L.1
Cantley, L.C.2
-
31
-
-
77954230384
-
Regulation of aurora B kinase by the lipid raft protein flotillin-1
-
Gomez V, Sese M, Santamaria A, Martinez JD, Castellanos E, Soler M et al. Regulation of aurora B kinase by the lipid raft protein flotillin-1. J Biol Chem 2010; 285: 20683-20690.
-
(2010)
J Biol Chem
, vol.285
, pp. 20683-20690
-
-
Gomez, V.1
Sese, M.2
Santamaria, A.3
Martinez, J.D.4
Castellanos, E.5
Soler, M.6
-
32
-
-
80054827742
-
Research advances on flotillins
-
Zhao F, Zhang J, Liu YS, Li L, He YL. Research advances on flotillins. Virol J 2011; 8: 479.
-
(2011)
Virol J
, vol.8
, pp. 479
-
-
Zhao, F.1
Zhang, J.2
Liu, Y.S.3
Li, L.4
He, Y.L.5
-
34
-
-
0036789884
-
Chaperonedependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/ Neu
-
Xu W, Marcu M, Yuan X, Mimnaugh E, Patterson C, Neckers L. Chaperonedependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/ Neu. Proc Natl Acad Sci USA 2002; 99: 12847-12852.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 12847-12852
-
-
Xu, W.1
Marcu, M.2
Yuan, X.3
Mimnaugh, E.4
Patterson, C.5
Neckers, L.6
-
35
-
-
0037853218
-
ErbB2 degradation mediated by the co-chaperone protein CHIP
-
DOI 10.1074/jbc.M209640200
-
Zhou P, Fernandes N, Dodge IL, Reddi AL, Rao N, Safran H et al. ErbB2 degradation mediated by the co-chaperone protein CHIP. J Biol Chem 2003; 278: 13829-13837. (Pubitemid 36799921)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.16
, pp. 13829-13837
-
-
Zhou, P.1
Fernandes, N.2
Dodge, I.L.3
Lakku Reddi, A.4
Rao, N.5
Safran, H.6
DiPetrillo, T.A.7
Wazer, D.E.8
Band, V.9
Band, H.10
-
36
-
-
84857746692
-
Flotillin-1/reggie-2 plays a dual role in the activation of receptor tyrosine kinase/ map kinase signaling
-
Amaddii M, Meister M, Banning A, Tomasovic A, Mooz J, Rajalingam K et al. Flotillin-1/reggie-2 plays a dual role in the activation of receptor tyrosine kinase/ map kinase signaling. J Biol Chem 2012; 287: 7265-7278.
-
(2012)
J Biol Chem
, vol.287
, pp. 7265-7278
-
-
Amaddii, M.1
Meister, M.2
Banning, A.3
Tomasovic, A.4
Mooz, J.5
Rajalingam, K.6
-
37
-
-
84855335580
-
Molecular networks in FGF signaling: Flotillin-1 and Cbl-associated protein compete for the binding to fibroblast growth factor receptor substrate 2
-
Tomasovic A, Traub S, Tikkanen R. Molecular networks in FGF signaling: Flotillin-1 and Cbl-associated protein compete for the binding to fibroblast growth factor receptor substrate 2. PLoS One 2012; 7: e29739.
-
(2012)
PLoS One
, vol.7
-
-
Tomasovic, A.1
Traub, S.2
Tikkanen, R.3
-
38
-
-
5644300960
-
Up-regulation of flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1
-
DOI 10.1158/0008-5472.CAN-04-0823
-
Hazarika P, McCarty MF, Prieto VG, George S, Babu D, Koul D et al. Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1. Cancer Res 2004; 64: 7361-7369. (Pubitemid 39372075)
-
(2004)
Cancer Research
, vol.64
, Issue.20
, pp. 7361-7369
-
-
Hazarika, P.1
McCarty, M.F.2
Prieto, V.G.3
George, S.4
Babu, D.5
Koul, D.6
Bar-Eli, M.7
Duvic, M.8
-
39
-
-
79956033520
-
Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a
-
Lin C, Wu Z, Lin X, Yu C, Shi T, Zeng Y et al. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a. Clin Cancer Res 2011; 17: 3089-3099.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 3089-3099
-
-
Lin, C.1
Wu, Z.2
Lin, X.3
Yu, C.4
Shi, T.5
Zeng, Y.6
-
40
-
-
32544454618
-
Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer
-
DOI 10.1016/j.mce.2005.11.020, PII S0303720705004260
-
Marquez DC, Chen HW, Curran EM, Welshons WV, Pietras RJ. Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol Cell Endocrinol 2006; 246: 91-100. (Pubitemid 43238401)
-
(2006)
Molecular and Cellular Endocrinology
, vol.246
, Issue.1-2
, pp. 91-100
-
-
Marquez, D.C.1
Chen, H.-W.2
Curran, E.M.3
Welshons, W.V.4
Pietras, R.J.5
-
41
-
-
77954372744
-
FOXO1A is a target for HER2-overexpressing breast tumors
-
Wu Y, Shang X, Sarkissyan M, Slamon D, Vadgama JV. FOXO1A is a target for HER2-overexpressing breast tumors. Cancer Res 2010; 70: 5475-5485.
-
(2010)
Cancer Res
, vol.70
, pp. 5475-5485
-
-
Wu, Y.1
Shang, X.2
Sarkissyan, M.3
Slamon, D.4
Vadgama, J.V.5
-
42
-
-
0031822837
-
Tissue microarrays for high-throughput molecular profiling of tumor specimens
-
DOI 10.1038/nm0798-844
-
Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844-847. (Pubitemid 28331029)
-
(1998)
Nature Medicine
, vol.4
, Issue.7
, pp. 844-847
-
-
Kononen, J.1
Bubendorf, L.2
Kallioniemi, A.3
Barlund, M.4
Schraml, P.5
Leighton, S.6
Torhorst, J.7
Mihatsch, M.J.8
Sauter, G.9
Kallioniemi, O.-P.10
-
43
-
-
0031915998
-
Prognostic and predictive factors in breast cancer by immunohistochemical analysis
-
Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998; 11: 155-168. (Pubitemid 28144151)
-
(1998)
Modern Pathology
, vol.11
, Issue.2
, pp. 155-168
-
-
Allred, D.C.1
Harvey, J.M.2
Berardo, M.3
Clark, G.M.4
|